3D cell culture systems modeling tumor growth determinants in cancer target discovery
CR Thoma, M Zimmermann, I Agarkova… - Advanced drug delivery …, 2014 - Elsevier
Phenotypic heterogeneity of cancer cells, cell biological context, heterotypic crosstalk and
the microenvironment are key determinants of the multistep process of tumor development …
the microenvironment are key determinants of the multistep process of tumor development …
Polymers in cell encapsulation from an enveloped cell perspective
P de Vos, HA Lazarjani, D Poncelet… - Advanced drug delivery …, 2014 - Elsevier
In the past two decades, many polymers have been proposed for producing
immunoprotective capsules. Examples include the natural polymers alginate, agarose …
immunoprotective capsules. Examples include the natural polymers alginate, agarose …
Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids
RW Jenkins, AR Aref, PH Lizotte, E Ivanova, S Stinson… - Cancer discovery, 2018 - AACR
Ex vivo systems that incorporate features of the tumor microenvironment and model the
dynamic response to immune checkpoint blockade (ICB) may facilitate efforts in precision …
dynamic response to immune checkpoint blockade (ICB) may facilitate efforts in precision …
Cell and environment interactions in tumor microregions: the multicell spheroid model
RM Sutherland - Science, 1988 - science.org
Abnormal vascularization of malignant tumors is associated with the development of
microregions of heterogeneous cells and environments. Experimental models such as …
microregions of heterogeneous cells and environments. Experimental models such as …
[HTML][HTML] Induction of hypoxia and necrosis in multicellular tumor spheroids is associated with resistance to chemotherapy treatment
S Däster, N Amatruda, D Calabrese, R Ivanek… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Culture of cancerous cells in standard monolayer conditions poorly mirrors growth in three-
dimensional architectures typically observed in a wide majority of cancers of different …
dimensional architectures typically observed in a wide majority of cancers of different …
Nonlinear modelling of cancer: bridging the gap between cells and tumours
Despite major scientific, medical and technological advances over the last few decades, a
cure for cancer remains elusive. The disease initiation is complex, and including initiation …
cure for cancer remains elusive. The disease initiation is complex, and including initiation …
Alginate-based microcapsules for immunoisolation of pancreatic islets
Transplantation of microencapsulated cells is proposed as a therapy for the treatment of a
wide variety of diseases since it allows for transplantation of endocrine cells in the absence …
wide variety of diseases since it allows for transplantation of endocrine cells in the absence …
Three-dimensional cell cultures: from molecular mechanisms to clinical applications
W Mueller-Klieser - American Journal of Physiology-Cell …, 1997 - journals.physiology.org
This article reviews actual advances in the development and application of three-
dimensional (3-D) cell culture systems. Recent therapeutically oriented studies include …
dimensional (3-D) cell culture systems. Recent therapeutically oriented studies include …
Multicellular spheroids: a review on cellular aggregates in cancer research
W Mueller-Klieser - Journal of cancer research and clinical oncology, 1987 - Springer
Cellular aggregates have been used in developmental biology and in experimental cancer
research for several decades. Spherical aggregates of malignant cells, ie multicellular tumor …
research for several decades. Spherical aggregates of malignant cells, ie multicellular tumor …
Multicellular resistance: a paradigm for clinical resistance?
B Desoize, JC Jardillier - Critical reviews in oncology/hematology, 2000 - Elsevier
Research on resistance to cancer treatment was mainly focused for 20 years on multidrug
resistance (MDR). No useful method of reversing MDR, suitable for clinical use, has yet …
resistance (MDR). No useful method of reversing MDR, suitable for clinical use, has yet …